Increase in ageing population who are prone to or has risk of respiratory infections will boost market growth; increasing incidences of hereditary diseases, lung disorders and increasing pollution due to the high discharge of harmful chemicals are significant reasons for chronic respiratory diseases and are the major factors influencing the growth of market for dry powder inhaler devices.
Market Size – USD 643.1 Million in 2018, Market Growth - CAGR of 4.4%, Market Trends –Increase in ageing population globally who are prone to respiratory infections.
NEW YORK, April 01, 2019 (GLOBE NEWSWIRE) -- The global Dry Powder Inhaler Device Market is estimated to reach USD 912.3 Million by 2026, according to a new report by Reports and Data. This can be mainly associated due to increasing incidences of hereditary diseases, lung disorders and increasing pollution due to the high discharge of harmful chemicals are significant reasons for chronic respiratory diseases that are generating a significant demand for the dry powder inhalers. Improvised efficiency of dry powder inhalers and better results in comparison with alternative therapies is a driving factor that will aid market growth. Based on statistics, the rise in elderly population base inclined to respiratory infections will boost market growth. A significant cause of lung disorders in teenagers and adults is the addiction to nicotine. Increases in variations of hormones due to the changing lifestyle which can trigger the need for having an addiction are also significant factors stimulating Market demand.
Premium Sample report available on demand: https://www.reportsanddata.com/sample-enquiry-form/1233
Dry powder inhaler market in North America accounts for the largest share of 22.30% in 2018, which is driven due to the presence of world-class healthcare infrastructure with technologically advanced practice, a high number of people with respiratory problems, higher spending, strict guidelines and presence of leading industry players in the region. The U.S. will boost the North America dry powder inhaler industry due to the increasing predominance of asthma and other respiratory diseases copulated with the growing geriatric population. Adoption of new technologies will further propel the growth of dry powder inhaler devices.
Further key findings from the report suggest
- The asthma segment is valued at USD 205.1 million in 2018 and is estimated to reach USD 299.2 million by 2026 at a CAGR of 4.7% during the forecast period, due to an increase in air pollution levels across the world and increase in the incidence of asthma particularly in developed countries.
- Single-use devices are observing improved demand as they have the potential to overcome the challenges and offer a hygienic & clean device. This segment is valued at USD 393.5 million in 2018 and is estimated to reach USD 563.8 million by 2026 at a CAGR of 4.5% during the forecast period. A significant trend in the market is the demand for accessibility and easy handling of respiratory devices.
- Multiple dry powder inhalers are popular among patients with respiratory diseases as an additional device for different places such as cars, homes and job sites. With single-use dry powder inhalers, patients are allowed to carry the exact dose of inhalations needed in blister packs, which in turn promotes handling and comfort.
- The chronic obstructive pulmonary diseases (COPD) sector of the application segment accounts for a market share of 21.50% in 2018 and is estimated to reach USD 202.5 million by 2026 at a CAGR of 4.8%.
- Increase in incidence of respiratory disorders including asthma and COPD, increase in air pollution levels especially in emerging countries, and an increase in per capita health care spending are the major factors increasing demand and utilization of dry powder inhalers worldwide.
- Increase in variations of hormones due to the changing lifestyle which can trigger the need for having an addiction will show enhanced demand for dry powder inhaler industry growth.
- The rise in the number of prescriptions for dried powder inhalers by hospitals due to the growth rate of adoption shown by doctors boost the market growth. Among the end users segment, the hospital sector is anticipated to grow at a CAGR of 4.6%. IT accounts for the largest market share of 46.41% in 2018. The growth in this market segment is due to the availability of these inhalers in the pharmacies and presence of strong business channels.
- Lifestyle changes and rise in the occurrence of allergies and infections amongst the population has driven to an extended demand for dry powder inhalers in the overall market in Europe. Industrialization and excessive use of chemicals have further increased the occurrence of respiratory ailments in workers that have led to market development.
- Other regions such as APAC are estimated to register the highest CAGR of 5.1 %, during the forecast period. APAC is anticipated to have the fastest growth, due to a rapidly emerging medical infrastructure, increasing expenses on healthcare and rising medical tourism in developing nations such as China and India in this region.
- Key participants include 3M Company, Astrazeneca Plc., Chiesi Farmaceutici S.p.A., GlaxoSmithKline Plc, Novartis AG, Cipla Ltd., Teva Pharmaceutical Industries Limited, Boehringer Ingelheim GmbH, MannKind Corporation, and Vectura Group Plc.
Read more at: https://www.reportsanddata.com/report-detail/dry-powder-inhaler-device-market
For the purpose of this report, Reports and Data have segmented global Dry Powder Inhaler Device Market on the basis of Type, Product, Application, End Users and region:
Product Outlook (Volume, Thousand Units; and Revenue, USD Million; 2016-2026)
- Capsule based
- Blister based
- Reservoir/Cartridge based
- Others
End User Outlook (Volume, Thousand Units; and Revenue, USD Million; 2016-2026)
- Hospitals and pharmacies
- Retail pharmacies
- Drug stores
Application Outlook (Volume, Thousand Units; and Revenue, USD Million; 2016-2026)
- Asthma
- COPD
- Diabetes
- Hereditary diseases
- Other
Type Outlook (Volume, Thousand Units; and Revenue, USD Million; 2016-2026)
- Single dose
- Multi-dose
Order Now (Customized report delivered as per your specific requirement): https://www.reportsanddata.com/checkout-form/1234
Regional Outlook (Volume, Kilo Tons; and Revenue, USD Million; 2016-2026)
- North America
- U.S.
- Europe
- Germany
- UK
- Asia Pacific
- China
- India
- South-east Asia
- Latin America
- Brazil
- MEA
Browse More Reports of Medical Devices Category At: https://www.reportsanddata.com/report/category/medical-devices
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John Watson
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-800-819-3052
E-mail: sales@reportsanddata.com